Pediatrix Medical Group, Inc. (MD) research
Pediatrix Medical Group, Inc.- Sector
- Health Care
- Last price
- $25.93
- As of
Pediatrix Medical Group, Inc. (MD): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-04.
As of . Source: SEC EDGAR filings for MD. Method and limitations.
Share the MD intelligence card
See MD live in the terminal
Track MD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live MD terminal, freeActive signals for MD
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 12.9% - EPS $0.44 vs $0.3898 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 21.1% - EPS $0.53 vs $0.4375 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 39.7% - EPS $0.67 vs $0.4797 estimate
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 9.9% - EPS $0.5 vs $0.5552 estimate
FREE, NO ACCOUNT
Every signal on MD, as it fires
New filings, 13F moves and cross asset signals on MD land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in MD (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 58502B106 · 2026Q2 | $40.9M | 0.02% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 58502B106 · 2026Q2 | $32.6M | 0.04% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 58502B106 · 2026Q2 | $1.4M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 58502B106 · 2026Q2 | $1.2M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MD
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
MD mentioned in Kresmion daily briefs
MD against its peers
MD's operating margin of 10.9% ranks in the 88th percentile of 19 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-03.
| Metric | MD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 1.9B USD | 1.2B USD | 60 | 20 |
| Gross margin | n/a | 59.9% | n/a | 15 |
| Operating margin | 10.9% | 0.4% | 88 | 19 |
| Net margin | 8.6% | 0.1% | 79 | 20 |
| Return on equity | 19.1% | 0.2% | 88 | 19 |
| P / E | 13.4x | 31.3x | 15 | 9 |
Peers (20): ALHC, PGNY, SEM, INSP, XRAY, NVCR, LMAT, PRVA, ACHC, BKD, ATEC, ATRC, AVAH, OMCL, TMDX, WGS, CNMD, PNTG, AMN, OMDA. Fiscal periods ending between 2025-12-31 and 2026-01-03. Every figure is one full fiscal year read from one annual filing (MD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more MD signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to MDand get the insider, 13F, options, and confluence read in one view.